TSS
APRE icon

Two Sigma Securities’s Aprea Therapeutics APRE Stock Holding History

Two Sigma Securities’s Portfolio APRE Stock Details APRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.3K Buy
+13,500
New +$10.6K ﹤0.01% 1461
2021
Q3 		– Sell
-598
Closed -$58K – 1536
2021
Q2 		$58K Buy
+598
New +$55.3K ﹤0.01% 1386

Other funds holding APRE

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SRL
Scientech Research LLC Jersey City, New Jersey $120M AUM 73.62% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Two Sigma Securities's APRE Position: Q1 2026 in Review

Two Sigma Securities opened a new position in Aprea Therapeutics (APRE) in Q1 2026: 13,500 shares worth $10.3K. The stake represents ﹤0.01% of the portfolio and ranks #1461 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in APRE as recently as Q2 2021.

Two Sigma Securities first reported a position in APRE in Q2 2021 and has held it in 2 quarters since. The position peaked at $58K in Q2 2021. 22 funds tracked by Wall St. Rank hold APRE as of Q1 2026.

  • Two Sigma Securities held 13,500 shares of Aprea Therapeutics worth $10.3K as of Q1 2026.
  • Aprea Therapeutics was a new Two Sigma Securities position in Q1 2026.
  • Aprea Therapeutics made up ﹤0.01% of Two Sigma Securities's portfolio in Q1 2026, its #1461 holding.
  • Two Sigma Securities first reported a position in Aprea Therapeutics in Q2 2021 and has held it in 2 quarters since.
  • Two Sigma Securities's Aprea Therapeutics position peaked at $58K in Q2 2021.
  • 22 funds tracked by Wall St. Rank held Aprea Therapeutics as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.